- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/20 - Pills, lozenges or tablets
Patent holdings for IPC class A61K 9/20
Total number of patents in this class: 14078
10-year publication summary
|
1062
|
1156
|
1082
|
1176
|
1161
|
1136
|
1001
|
960
|
927
|
668
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10741 |
142 |
| Sanovel Ilac Sanayi ve Ticaret A.S. | 285 |
137 |
| Fertin Pharma A/S | 254 |
107 |
| Antecip Bioventures II LLC | 337 |
103 |
| Boehringer Ingelheim International GmbH | 4641 |
96 |
| Takeda Pharmaceutical Company Limited | 2711 |
88 |
| Axsome Therapeutics, Inc. | 258 |
86 |
| ratiopharm GmbH | 301 |
83 |
| Daiichi Sankyo Company, Limited | 1878 |
76 |
| Synthon BV | 316 |
76 |
| Merck Patent GmbH | 5812 |
71 |
| Purdue Pharma L.P. | 501 |
70 |
| Hanmi Pharm. Co., Ltd. | 572 |
67 |
| Vertex Pharmaceuticals Incorporated | 1602 |
64 |
| Gilead Sciences, Inc. | 2035 |
61 |
| AstraZeneca AB | 2897 |
60 |
| Novo Nordisk A/S | 2286 |
59 |
| Hoffmann-La Roche Inc. | 3447 |
56 |
| Lupin Limited | 434 |
54 |
| DSM IP Assets B.V. | 5589 |
53 |
| Other owners | 12469 |